Howe & Rusling’s Core Laboratories CLB Stock Holding History

Howe & Rusling’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-77	Closed	-$3K	–	789
2019 Q4	$3K	Sell	77 -40	-34%	-$1.8K	﹤0.01%	612
2019 Q3	$5K	Hold	117	–	–	﹤0.01%	545
2019 Q2	$6K	Sell	117 -10	-8%	-$587	﹤0.01%	503
2019 Q1	$9K	Sell	127 -29	-19%	-$1.94K	﹤0.01%	460
2018 Q4	$9K	Buy	156 +7	+5%	+$604	﹤0.01%	452
2018 Q3	$17K	Buy	149 +31	+26%	+$3.5K	﹤0.01%	410
2018 Q2	$15K	Hold	118	–	–	﹤0.01%	394
2018 Q1	$13K	Buy	118 +54	+84%	+$5.98K	﹤0.01%	446
2017 Q4	$7K	Hold	64	–	–	﹤0.01%	507
2017 Q3	$6K	Hold	64	–	–	﹤0.01%	548
2017 Q2	$6K	Hold	64	–	–	﹤0.01%	582
2017 Q1	$7K	Hold	64	–	–	﹤0.01%	589
2016 Q4	$8K	Hold	64	–	–	﹤0.01%	551
2016 Q3	$7K	Sell	64 -6	-9%	-$691	﹤0.01%	585
2016 Q2	$9K	Hold	70	–	–	﹤0.01%	501
2016 Q1	$8K	Buy	70 +24	+52%	+$2.49K	﹤0.01%	569
2015 Q4	$5K	Hold	46	–	–	﹤0.01%	620
2015 Q3	$5K	Hold	46	–	–	﹤0.01%	625
2015 Q2	$5K	Hold	46	–	–	﹤0.01%	632
2015 Q1	$5K	Buy	+46	New	+$4.9K	﹤0.01%	601

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Howe & Rusling's CLB Position: Q1 2020 in Review

Howe & Rusling sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 77 shares — an estimated $3K sold.

Howe & Rusling first reported a position in CLB in Q1 2015 and held it in 20 quarters. The position peaked at $17K in Q3 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Howe & Rusling reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Howe & Rusling sold 77 Core Laboratories shares in Q1 2020, an estimated $3K.
Howe & Rusling first reported a position in Core Laboratories in Q1 2015 and held it in 20 quarters.
Howe & Rusling's Core Laboratories position peaked at $17K in Q3 2018.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Howe & Rusling's 13F filing for Q1 2020, filed 14 May 2020.